首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1789376

生物膜處理市場：按處理方法、按產品、按感染疾病類型、按病原體類型、按最終用戶、按地區

Biofilm Treatment Market, By Treatment Method, By Product, By Infection Type, By Pathogen Type,By End User, By Geography

出版日期: 2025年07月28日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

生物膜處理市場規模預計在 2025 年為 23.8 億美元，預計到 2032 年將達到 41.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 8.20%。

分析範圍		分析詳細資訊
基準年	2024	市場規模（2025年）	23.8億美元
效能數據	2020-2024	預測期	2025-2032
預測期間的複合年成長率（2025-2032年）	8.20%	預計金額（2032年）	41.3億美元

全球生物膜治療市場是醫療保健和生物技術產業中一個快速發展的領域，致力於解決現代醫學中最持久的挑戰之一。生物膜是由自身產生的細胞外聚合物包覆的複雜微生物群落，這些聚合物附著在醫療設備、組織和環境基材等表面。這些結構化的微生物群落對傳統抗菌治療表現出顯著的抵抗力，約80%的人類微生物感染疾病是由其引起的。

醫療植入、導管、假體裝置和慢性傷口上的生物膜形成會帶來重大的臨床挑戰，包括治療失敗、延長住院時間和增加醫療費用。生物膜治療市場涵蓋多種治療方法，包括抗菌藥物、酵素治療、物理破壞方法以及旨在預防生物膜形成或有效去除已形成的生物膜結構的新型生物技術解決方案。慢性病盛行率的上升、醫療植入使用量的增加、對生物膜相關感染疾病認知的提高以及對抗抗菌素抗藥性的迫切需求，引起了全球製藥公司、醫療設備製造商和醫療保健提供商的極大關注，推動了先進生物膜管理解決方案的創新和投資。

市場動態

全球生物膜治療市場受多個關鍵因素驅動，這些因素推動了其強勁的成長軌跡。主要促進因素是慢性傷口盛行率的上升，尤其是糖尿病足潰瘍和壓瘡。這些傷口極易形成生物膜，因而嚴重阻礙癒合過程。老年人群更容易患慢性疾病，需要頻繁的醫療干預，包括植入式器械。

此外，整形外科假體、心血管設備和導尿管等醫療植入的日益普及創造了巨大的市場機會，因為這些設備為生物膜的培養提供了肥沃的表面。醫療保健專業人員對生物膜相關併發症及其對治療結果的影響的認知不斷提高，導致診斷和治療性介入的增加。

然而，生物膜市場面臨許多限制，例如生物膜由於結構複雜，難以治療，且通常需要聯合治療，導致成本高且治療時間延長。此外，新型生物膜治療產品的監管障礙也構成了重大障礙，因為需要進行大規模臨床試驗來證明其對多種微生物群的有效性。

許多醫療保健系統對高級生物膜治療的報銷範圍有限，這進一步抑制了市場成長。然而，諸如基於奈米技術的解決方案、動態療法和個人化醫療方法等創新治療方法的開發仍存在巨大的商機。用於快速檢測生物膜的照護現場診斷工具的出現帶來了豐厚的前景，而將人工智慧融入治療計劃則為市場擴張和改善患者預後提供了一條充滿希望的途徑。

本報告的主要特點

本報告對全球生物膜處理市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
它還強調了每個領域的潛在商機，並描述了該市場的一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球生物膜處理市場的主要企業已根據以下參數進行了分析，例如公司概況、產品系列、主要亮點、財務表現和策略。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
「全球生物膜處理市場」報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球生物膜處理市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2.38 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.20%	2032 Value Projection:	USD 4.13 Bn

The global biofilm treatment market represents a rapidly evolving segment within the healthcare and biotechnology industries, addressing one of the most persistent challenges in modern medicine. Biofilms are complex microbial communities encased in self-produced extracellular polymeric substances that adhere to surfaces, including medical devices, tissues, and environmental substrates. These structured microbial communities exhibit remarkable resistance to conventional antimicrobial treatments, making them responsible for approximately 80% of all microbial infections in humans.

The formation of biofilms on medical implants, catheters, prosthetic devices, and chronic wounds poses significant clinical challenges, leading to treatment failures, prolonged hospital stays, and increased healthcare costs. The biofilm treatment market encompasses various therapeutic approaches including antimicrobial agents, enzymatic treatments, physical disruption methods, and novel biotechnological solutions designed to prevent biofilm formation or effectively eliminate established biofilm structures. With the rising prevalence of chronic diseases, increasing use of medical implants, growing awareness about biofilm-related infections, and the urgent need to combat antimicrobial resistance, this market has gained substantial attention from pharmaceutical companies, medical device manufacturers, and healthcare providers worldwide, driving innovation and investment in advanced biofilm management solutions.

Market Dynamics

The global biofilm treatment market is propelled by several key drivers that collectively fuel its robust growth trajectory. The primary driver is the escalating prevalence of chronic wounds, particularly diabetic foot ulcers and pressure sores, which are highly susceptible to biofilm formation and significantly impede healing processes. The aging global population further amplifies this demand as elderly individuals are more prone to chronic conditions and require frequent medical interventions involving implantable devices.

Additionally, the increasing adoption of medical implants, including orthopedic prosthetics, cardiovascular devices, and urinary catheters, creates a substantial market opportunity as these devices serve as prime surfaces for biofilm development. The growing awareness among healthcare professionals about biofilm-related complications and their impact on treatment outcomes has led to increased diagnostic and therapeutic interventions.

However, the market faces notable restraints including the complex nature of biofilm structures that make treatment challenging and often require combination therapies, leading to higher costs and extended treatment durations. Regulatory hurdles for novel biofilm treatment products also pose significant barriers, as demonstrating efficacy against diverse microbial communities requires extensive clinical trials.

The limited reimbursement coverage for advanced biofilm treatments in many healthcare systems further constrains market growth. Nevertheless, substantial opportunities exist in the development of innovative treatment modalities such as nanotechnology-based solutions, photodynamic therapy, and personalized medicine approaches. The emergence of point-of-care diagnostic tools for rapid biofilm detection presents lucrative prospects, while the integration of artificial intelligence in treatment planning offers promising avenues for market expansion and enhanced patient outcomes.

Key Features of the Study

This report provides in-depth analysis of the global biofilm treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global biofilm treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include leading pharmaceutical companies, medical device manufacturers, biotechnology firms, and specialized biofilm treatment solution providers.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global biofilm treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biofilm treatment market.

Market Segmentation

Treatment Method Insights (Revenue, USD Bn, 2020 - 2032)
- Antimicrobial Agents (Antibiotics)
- Disinfectants
- Enzymes (e.g., DNase, Dispersin B)
- Surfactants (Anionic, Cationic Surfactants)
- Phage Therapy Products (Bacteriophages)
- Nanoparticles
- Photodynamic Therapy
- Medical Device Coatings (Anti-adhesive Coatings, etc.)
Product Insights (Revenue, USD Bn, 2020 - 2032)
- Debridement Equipment
- Gauzes and Dressings
- Antimicrobial Gels, Ointments, and Sprays
- Wipes, Pads, and Lavage Solutions
- Others (Grafts and Matrices)
Infection Type Insights (Revenue, USD Bn, 2020 - 2032)
- Chronic Wound Infections
- Implant-related Infections
- Dental Biofilms
- Sinusitis and Ear Infections
- Urinary Tract Infections (UTIs)
- Gastrointestinal Infections
- Respiratory Infections
- Osteomyelitis (Bone Infections)
Pathogen Type Insights (Revenue, USD Bn, 2020 - 2032)
- Fungal Biofilms
- Viral Biofilms
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Dental Clinics
- Biopharmaceutical Industries
- Veterinary Hospitals
- Diagnostic Laboratories
- Others (Academic and Research Institutions, etc.)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Smith and Nephew plc
- ConvaTec Group PLC
- Kane Biotech Inc.
- Ecolab Inc.
- Microbion Corp.
- Kane Biotech Inc.
- Nelson Laboratories, LLC
- BioSurface Technologies
- Other Prominent Players

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biofilm Treatment Market, By Treatment Method
- Global Biofilm Treatment Market, By Product
- Global Biofilm Treatment Market, By Infection Type
- Global Biofilm Treatment Market, By Pathogen Type
- Global Biofilm Treatment Market, By End User
- Global Biofilm Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Biofilm Treatment Market, By Treatment Method, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antimicrobial Agents (Antibiotics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Disinfectants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Enzymes (e.g., DNase, Dispersin B)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Surfactants (Anionic, Cationic Surfactants)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Phage Therapy Products (Bacteriophages)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nanoparticles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Photodynamic Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Coatings (Anti-adhesive Coatings, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Biofilm Treatment Market, By Product, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Debridement Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gauzes and Dressings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antimicrobial Gels, Ointments, and Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Wipes, Pads, and Lavage Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Grafts and Matrices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Biofilm Treatment Market, By Infection Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Chronic Wound Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Implant-related Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dental Biofilms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sinusitis and Ear Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Urinary Tract Infections (UTIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gastrointestinal Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Osteomyelitis (Bone Infections)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biofilm Treatment Market, By Pathogen Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Fungal Biofilms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Viral Biofilms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Biofilm Treatment Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dental Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biopharmaceutical Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Academic and Research Institutions, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Biofilm Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Treatment Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Infection Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pathogen Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Smith and Nephew plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ConvaTec Group PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kane Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ecolab Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Microbion Corp.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kane Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nelson Laboratories, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioSurface Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Other Prominent Players
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies